Literature DB >> 9154383

Effect of a beta-adrenergic antagonist, propranolol, on induced HSV-1 ocular recurrence in latently infected rabbits.

H H Garza1, J M Hill.   

Abstract

PURPOSE: Propranolol, a beta-adrenergic antagonist, has been shown to block hyperthermically-induced ocular recurrence of HSV-1 in mice and reduce spontaneous ocular viral shedding and herpetic corneal lesions in latently infected rabbits. The present study was performed to determine the effect of propranolol on epinephrine iontophoresis-induced ocular recurrence and immunosuppression-induced ocular recurrence in the rabbit eye model.
METHODS: New Zealand white rabbits were infected with HSV-1 strain 17Syn+ or McKrae. After latency was established, the animals were injected intramuscularly with saline (placebo), or propranolol (5-200 mg/kg) twice daily, and then induced with epinephrine iontophoresis or cyclophosphamide and dexamethasone administration. Tear film swabs were cultured to determine the frequency of viral shedding.
RESULTS: Propranolol administered at a range of doses did not affect the frequency or duration of viral shedding following epinephrine or cyclophosphamide/dexamethasone induction as compared to saline treatment.
CONCLUSION: These results demonstrate that propranolol does not significantly reduce ocular HSV-1 shedding following induction by epinephrine iontophoresis or immunosuppression. By inference, these results suggest two possibilities: (1) that viral pathways leading to spontaneous and induced shedding of virus are under separate control mechanisms or (2) in rabbits, these inducers are of such potency that propranolol is ineffectual.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154383     DOI: 10.1076/ceyr.16.5.453.7051

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  Regulation of herpes simplex virus type 1 thymidine kinase gene expression by thyroid hormone receptor in cultured neuronal cells.

Authors:  Shao-Chung V Hsia; Rajeswara C Pinnoji; Gautam R Bedadala; James M Hill; Jayavardhana R Palem
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

2.  Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes.

Authors:  J M Loutsch; G C Perng; J M Hill; X Zheng; M E Marquart; T M Block; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  A Novel Thyroid Hormone Mediated Regulation of HSV-1 Gene Expression and Replication is Specific to Neuronal Cells and Associated with Disruption of Chromatin Condensation.

Authors:  Feng Chen; Jay Palem; Matthew Balish; Robert Figliozzi; Amakoe Ajavon; S Victor Hsia
Journal:  SOJ Pharm Pharm Sci       Date:  2014

4.  Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells.

Authors:  Gautam R Bedadala; Rajeswara C Pinnoji; Jayavardhana R Palem; Shao-Chung V Hsia
Journal:  Cell Res       Date:  2010-04-13       Impact factor: 25.617

5.  Overexpression of thyroid hormone receptor β1 altered thyroid hormone-mediated regulation of herpes simplex virus-1 replication in differentiated cells.

Authors:  Feng Chen; Robert W Figliozzi; Gautam Bedadala; Jayavardhana Palem; S Victor Hsia
Journal:  J Neurovirol       Date:  2016-02-03       Impact factor: 2.643

6.  HSV-1 latent rabbits shed viral DNA into their saliva.

Authors:  James M Hill; Nicole M Nolan; Harris E McFerrin; Christian Clement; Timothy P Foster; William P Halford; Konstantin G Kousoulas; Walter J Lukiw; Hilary W Thompson; Ethan M Stern; Partha S Bhattacharjee
Journal:  Virol J       Date:  2012-09-28       Impact factor: 4.099

Review 7.  Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.

Authors:  Jody M Webre; James M Hill; Nicole M Nolan; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Victor Hsia; Donna M Neumann; Timothy P Foster; Walter J Lukiw; Hilary W Thompson
Journal:  J Biomed Biotechnol       Date:  2012-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.